
Resources
Guides, research, and perspectives on R&D intelligence, IP strategy, and the future of AI enabled innovation.

Executive Summary
In 2024, US patent infringement jury verdicts totaled $4.19 billion across 72 cases. Twelve individual verdicts exceeded $100million. The largest single award—$857 million in General Access Solutions v.Cellco Partnership (Verizon)—exceeded the annual R&D budget of many mid-market technology companies. In the first half of 2025 alone, total damages reached an additional $1.91 billion.
The consequences of incomplete patent intelligence are not abstract. In what has become one of the most instructive IP disputes in recent history, Masimo’s pulse oximetry patents triggered a US import ban on certain Apple Watch models, forcing Apple to disable its blood oxygen feature across an entire product line, halt domestic sales of affected models, invest in a hardware redesign, and ultimately face a $634 million jury verdict in November 2025. Apple—a company with one of the most sophisticated intellectual property organizations on earth—spent years in litigation over technology it might have designed around during development.
For organizations with fewer resources than Apple, the risk calculus is starker. A mid-size materials company, a university spinout, or a defense contractor developing next-generation battery technology cannot absorb a nine-figure verdict or a multi-year injunction. For these organizations, the patent landscape analysis conducted during the development phase is the primary risk mitigation mechanism. The quality of that analysis is not a matter of convenience. It is a matter of survival.
And yet, a growing number of R&D and IP teams are conducting that analysis using general-purpose AI tools—ChatGPT, Claude, Microsoft Co-Pilot—that were never designed for patent intelligence and are structurally incapable of delivering it.
This report presents the findings of a controlled comparison study in which identical patent landscape queries were submitted to four AI-powered tools: Cypris (a purpose-built R&D intelligence platform),ChatGPT (OpenAI), Claude (Anthropic), and Microsoft Co-Pilot. Two technology domains were tested: solid-state lithium-sulfur battery electrolytes using garnet-type LLZO ceramic materials (freedom-to-operate analysis), and bio-based polyamide synthesis from castor oil derivatives (competitive intelligence).
The results reveal a significant and structurally persistent gap. In Test 1, Cypris identified over 40 active US patents and published applications with granular FTO risk assessments. Claude identified 12. ChatGPT identified 7, several with fabricated attribution. Co-Pilot identified 4. Among the patents surfaced exclusively by Cypris were filings rated as “Very High” FTO risk that directly claim the technology architecture described in the query. In Test 2, Cypris cited over 100 individual patent filings with full attribution to substantiate its competitive landscape rankings. No general-purpose model cited a single patent number.
The most active sectors for patent enforcement—semiconductors, AI, biopharma, and advanced materials—are the same sectors where R&D teams are most likely to adopt AI tools for intelligence workflows. The findings of this report have direct implications for any organization using general-purpose AI to inform patent strategy, competitive intelligence, or R&D investment decisions.

1. Methodology
A single patent landscape query was submitted verbatim to each tool on March 27, 2026. No follow-up prompts, clarifications, or iterative refinements were provided. Each tool received one opportunity to respond, mirroring the workflow of a practitioner running an initial landscape scan.
1.1 Query
Identify all active US patents and published applications filed in the last 5 years related to solid-state lithium-sulfur battery electrolytes using garnet-type ceramic materials. For each, provide the assignee, filing date, key claims, and current legal status. Highlight any patents that could pose freedom-to-operate risks for a company developing a Li₇La₃Zr₂O₁₂(LLZO)-based composite electrolyte with a polymer interlayer.
1.2 Tools Evaluated

1.3 Evaluation Criteria
Each response was assessed across six dimensions: (1) number of relevant patents identified, (2) accuracy of assignee attribution,(3) completeness of filing metadata (dates, legal status), (4) depth of claim analysis relative to the proposed technology, (5) quality of FTO risk stratification, and (6) presence of actionable design-around or strategic guidance.
2. Findings
2.1 Coverage Gap
The most significant finding is the scale of the coverage differential. Cypris identified over 40 active US patents and published applications spanning LLZO-polymer composite electrolytes, garnet interface modification, polymer interlayer architectures, lithium-sulfur specific filings, and adjacent ceramic composite patents. The results were organized by technology category with per-patent FTO risk ratings.
Claude identified 12 patents organized in a four-tier risk framework. Its analysis was structurally sound and correctly flagged the two highest-risk filings (Solid Energies US 11,967,678 and the LLZO nanofiber multilayer US 11,923,501). It also identified the University ofMaryland/ Wachsman portfolio as a concentration risk and noted the NASA SABERS portfolio as a licensing opportunity. However, it missed the majority of the landscape, including the entire Corning portfolio, GM's interlayer patents, theKorea Institute of Energy Research three-layer architecture, and the HonHai/SolidEdge lithium-sulfur specific filing.
ChatGPT identified 7 patents, but the quality of attribution was inconsistent. It listed assignees as "Likely DOE /national lab ecosystem" and "Likely startup / defense contractor cluster" for two filings—language that indicates the model was inferring rather than retrieving assignee data. In a freedom-to-operate context, an unverified assignee attribution is functionally equivalent to no attribution, as it cannot support a licensing inquiry or risk assessment.
Co-Pilot identified 4 US patents. Its output was the most limited in scope, missing the Solid Energies portfolio entirely, theUMD/ Wachsman portfolio, Gelion/ Johnson Matthey, NASA SABERS, and all Li-S specific LLZO filings.
2.2 Critical Patents Missed by Public Models
The following table presents patents identified exclusively by Cypris that were rated as High or Very High FTO risk for the proposed technology architecture. None were surfaced by any general-purpose model.

2.3 Patent Fencing: The Solid Energies Portfolio
Cypris identified a coordinated patent fencing strategy by Solid Energies, Inc. that no general-purpose model detected at scale. Solid Energies holds at least four granted US patents and one published application covering LLZO-polymer composite electrolytes across compositions(US-12463245-B2), gradient architectures (US-12283655-B2), electrode integration (US-12463249-B2), and manufacturing processes (US-20230035720-A1). Claude identified one Solid Energies patent (US 11,967,678) and correctly rated it as the highest-priority FTO concern but did not surface the broader portfolio. ChatGPT and Co-Pilot identified zero Solid Energies filings.
The practical significance is that a company relying on any individual patent hit would underestimate the scope of Solid Energies' IP position. The fencing strategy—covering the composition, the architecture, the electrode integration, and the manufacturing method—means that identifying a single design-around for one patent does not resolve the FTO exposure from the portfolio as a whole. This is the kind of strategic insight that requires seeing the full picture, which no general-purpose model delivered
2.4 Assignee Attribution Quality
ChatGPT's response included at least two instances of fabricated or unverifiable assignee attributions. For US 11,367,895 B1, the listed assignee was "Likely startup / defense contractor cluster." For US 2021/0202983 A1, the assignee was described as "Likely DOE / national lab ecosystem." In both cases, the model appears to have inferred the assignee from contextual patterns in its training data rather than retrieving the information from patent records.
In any operational IP workflow, assignee identity is foundational. It determines licensing strategy, litigation risk, and competitive positioning. A fabricated assignee is more dangerous than a missing one because it creates an illusion of completeness that discourages further investigation. An R&D team receiving this output might reasonably conclude that the landscape analysis is finished when it is not.
3. Structural Limitations of General-Purpose Models for Patent Intelligence
3.1 Training Data Is Not Patent Data
Large language models are trained on web-scraped text. Their knowledge of the patent record is derived from whatever fragments appeared in their training corpus: blog posts mentioning filings, news articles about litigation, snippets of Google Patents pages that were crawlable at the time of data collection. They do not have systematic, structured access to the USPTO database. They cannot query patent classification codes, parse claim language against a specific technology architecture, or verify whether a patent has been assigned, abandoned, or subjected to terminal disclaimer since their training data was collected.
This is not a limitation that improves with scale. A larger training corpus does not produce systematic patent coverage; it produces a larger but still arbitrary sampling of the patent record. The result is that general-purpose models will consistently surface well-known patents from heavily discussed assignees (QuantumScape, for example, appeared in most responses) while missing commercially significant filings from less publicly visible entities (Solid Energies, Korea Institute of EnergyResearch, Shenzhen Solid Advanced Materials).
3.2 The Web Is Closing to Model Scrapers
The data access problem is structural and worsening. As of mid-2025, Cloudflare reported that among the top 10,000 web domains, the majority now fully disallow AI crawlers such as GPTBot andClaudeBot via robots.txt. The trend has accelerated from partial restrictions to outright blocks, and the crawl-to-referral ratios reveal the underlying tension: OpenAI's crawlers access approximately1,700 pages for every referral they return to publishers; Anthropic's ratio exceeds 73,000 to 1.
Patent databases, scientific publishers, and IP analytics platforms are among the most restrictive content categories. A Duke University study in 2025 found that several categories of AI-related crawlers never request robots.txt files at all. The practical consequence is that the knowledge gap between what a general-purpose model "knows" about the patent landscape and what actually exists in the patent record is widening with each training cycle. A landscape query that a general-purpose model partially answered in 2023 may return less useful information in 2026.
3.3 General-Purpose Models Lack Ontological Frameworks for Patent Analysis
A freedom-to-operate analysis is not a summarization task. It requires understanding claim scope, prosecution history, continuation and divisional chains, assignee normalization (a single company may appear under multiple entity names across patent records), priority dates versus filing dates versus publication dates, and the relationship between dependent and independent claims. It requires mapping the specific technical features of a proposed product against independent claim language—not keyword matching.
General-purpose models do not have these frameworks. They pattern-match against training data and produce outputs that adopt the format and tone of patent analysis without the underlying data infrastructure. The format is correct. The confidence is high. The coverage is incomplete in ways that are not visible to the user.
4. Comparative Output Quality
The following table summarizes the qualitative characteristics of each tool's response across the dimensions most relevant to an operational IP workflow.

5. Implications for R&D and IP Organizations
5.1 The Confidence Problem
The central risk identified by this study is not that general-purpose models produce bad outputs—it is that they produce incomplete outputs with high confidence. Each model delivered its results in a professional format with structured analysis, risk ratings, and strategic recommendations. At no point did any model indicate the boundaries of its knowledge or flag that its results represented a fraction of the available patent record. A practitioner receiving one of these outputs would have no signal that the analysis was incomplete unless they independently validated it against a comprehensive datasource.
This creates an asymmetric risk profile: the better the format and tone of the output, the less likely the user is to question its completeness. In a corporate environment where AI outputs are increasingly treated as first-pass analysis, this dynamic incentivizes under-investigation at precisely the moment when thoroughness is most critical.
5.2 The Diversification Illusion
It might be assumed that running the same query through multiple general-purpose models provides validation through diversity of sources. This study suggests otherwise. While the four tools returned different subsets of patents, all operated under the same structural constraints: training data rather than live patent databases, web-scraped content rather than structured IP records, and general-purpose reasoning rather than patent-specific ontological frameworks. Running the same query through three constrained tools does not produce triangulation; it produces three partial views of the same incomplete picture.
5.3 The Appropriate Use Boundary
General-purpose language models are effective tools for a wide range of tasks: drafting communications, summarizing documents, generating code, and exploratory research. The finding of this study is not that these tools lack value but that their value boundary does not extend to decisions that carry existential commercial risk.
Patent landscape analysis, freedom-to-operate assessment, and competitive intelligence that informs R&D investment decisions fall outside that boundary. These are workflows where the completeness and verifiability of the underlying data are not merely desirable but are the primary determinant of whether the analysis has value. A patent landscape that captures 10% of the relevant filings, regardless of how well-formatted or confidently presented, is a liability rather than an asset.
6. Test 2: Competitive Intelligence — Bio-Based Polyamide Patent Landscape
To assess whether the findings from Test 1 were specific to a single technology domain or reflected a broader structural pattern, a second query was submitted to all four tools. This query shifted from freedom-to-operate analysis to competitive intelligence, asking each tool to identify the top 10organizations by patent filing volume in bio-based polyamide synthesis from castor oil derivatives over the past three years, with summaries of technical approach, co-assignee relationships, and portfolio trajectory.
6.1 Query

6.2 Summary of Results

6.3 Key Differentiators
Verifiability
The most consequential difference in Test 2 was the presence or absence of verifiable evidence. Cypris cited over 100 individual patent filings with full patent numbers, assignee names, and publication dates. Every claim about an organization’s technical focus, co-assignee relationships, and filing trajectory was anchored to specific documents that a practitioner could independently verify in USPTO, Espacenet, or WIPO PATENT SCOPE. No general-purpose model cited a single patent number. Claude produced the most structured and analytically useful output among the public models, with estimated filing ranges, product names, and strategic observations that were directionally plausible. However, without underlying patent citations, every claim in the response requires independent verification before it can inform a business decision. ChatGPT and Co-Pilot offered thinner profiles with no filing counts and no patent-level specificity.
Data Integrity
ChatGPT’s response contained a structural error that would mislead a practitioner: it listed CathayBiotech as organization #5 and then listed “Cathay Affiliate Cluster” as a separate organization at #9, effectively double-counting a single entity. It repeated this pattern with Toray at #4 and “Toray(Additional Programs)” at #10. In a competitive intelligence context where the ranking itself is the deliverable, this kind of error distorts the landscape and could lead to misallocation of competitive monitoring resources.
Organizations Missed
Cypris identified Kingfa Sci. & Tech. (8–10 filings with a differentiated furan diacid-based polyamide platform) and Zhejiang NHU (4–6 filings focused on continuous polymerization process technology)as emerging players that no general-purpose model surfaced. Both represent potential competitive threats or partnership opportunities that would be invisible to a team relying on public AI tools.Conversely, ChatGPT included organizations such as ANTA and Jiangsu Taiji that appear to be downstream users rather than significant patent filers in synthesis, suggesting the model was conflating commercial activity with IP activity.
Strategic Depth
Cypris’s cross-cutting observations identified a fundamental chemistry divergence in the landscape:European incumbents (Arkema, Evonik, EMS) rely on traditional castor oil pyrolysis to 11-aminoundecanoic acid or sebacic acid, while Chinese entrants (Cathay Biotech, Kingfa) are developing alternative bio-based routes through fermentation and furandicarboxylic acid chemistry.This represents a potential long-term disruption to the castor oil supply chain dependency thatWestern players have built their IP strategies around. Claude identified a similar theme at a higher level of abstraction. Neither ChatGPT nor Co-Pilot noted the divergence.
6.4 Test 2 Conclusion
Test 2 confirms that the coverage and verifiability gaps observed in Test 1 are not domain-specific.In a competitive intelligence context—where the deliverable is a ranked landscape of organizationalIP activity—the same structural limitations apply. General-purpose models can produce plausible-looking top-10 lists with reasonable organizational names, but they cannot anchor those lists to verifiable patent data, they cannot provide precise filing volumes, and they cannot identify emerging players whose patent activity is visible in structured databases but absent from the web-scraped content that general-purpose models rely on.
7. Conclusion
This comparative analysis, spanning two distinct technology domains and two distinct analytical workflows—freedom-to-operate assessment and competitive intelligence—demonstrates that the gap between purpose-built R&D intelligence platforms and general-purpose language models is not marginal, not domain-specific, and not transient. It is structural and consequential.
In Test 1 (LLZO garnet electrolytes for Li-S batteries), the purpose-built platform identified more than three times as many patents as the best-performing general-purpose model and ten times as many as the lowest-performing one. Among the patents identified exclusively by the purpose-built platform were filings rated as Very High FTO risk that directly claim the proposed technology architecture. InTest 2 (bio-based polyamide competitive landscape), the purpose-built platform cited over 100individual patent filings to substantiate its organizational rankings; no general-purpose model cited as ingle patent number.
The structural drivers of this gap—reliance on training data rather than live patent feeds, the accelerating closure of web content to AI scrapers, and the absence of patent-specific analytical frameworks—are not transient. They are inherent to the architecture of general-purpose models and will persist regardless of increases in model capability or training data volume.
For R&D and IP leaders, the practical implication is clear: general-purpose AI tools should be used for general-purpose tasks. Patent intelligence, competitive landscaping, and freedom-to-operate analysis require purpose-built systems with direct access to structured patent data, domain-specific analytical frameworks, and the ability to surface what a general-purpose model cannot—not because it chooses not to, but because it structurally cannot access the data.
The question for every organization making R&D investment decisions today is whether the tools informing those decisions have access to the evidence base those decisions require. This study suggests that for the majority of general-purpose AI tools currently in use, the answer is no.
About This Report
This report was produced by Cypris (IP Web, Inc.), an AI-powered R&D intelligence platform serving corporate innovation, IP, and R&D teams at organizations including NASA, Johnson & Johnson, theUS Air Force, and Los Alamos National Laboratory. Cypris aggregates over 500 million data points from patents, scientific literature, grants, corporate filings, and news to deliver structured intelligence for technology scouting, competitive analysis, and IP strategy.
The comparative tests described in this report were conducted on March 27, 2026. All outputs are preserved in their original form. Patent data cited from the Cypris reports has been verified against USPTO Patent Center and WIPO PATENT SCOPE records as of the same date. To conduct a similar analysis for your technology domain, contact info@cypris.ai or visit cypris.ai.
The Patent Intelligence Gap - A Comparative Analysis of Verticalized AI-Patent Tools vs. General-Purpose Language Models for R&D Decision-Making
Blogs

With the growing interest in space flight and deep space exploration, more research is focusing on how to make life outside of earth habitable for human beings, and at what cost. In this blog, we’ll look at the market landscape of space travel, recent innovation activity, and scientific literature to gain a full picture of where our understanding of life beyond earth is headed.
Market Overview:
According to the Cypris Innovation Dashboard, over the past year alone, 15 new organizations entered the space travel industry (13 of which were startups) and the majority were based in USA. The past year also saw 406 new patents across 22 different countries, 10,549 new research papers, and 26,156 news articles published in the space. The majority of news articles focused on new products, and across the board media coverage was positive.

Of the patents published, 15.46% were created by the top 3 entities: NANJING SANLE GROUP CO LTD, ANHUI HUADONG PHOTOELEC TECH, and EMULATE INC. Below, you can see the breakdown of patent activity by region.

In the recent months, a number of new scientific studies have been released on efforts to make life in outer space habitable for human beings, and the impact of travel on the body and brain. Let's dive into a few of these findings.
Creating Oxygen in Space Using Magnets:

Researchers at the University of Warwick have invented a new way to make oxygen for astronauts using magnets. To provide oxygen in space, NASA currently uses centrifuges, which are large machines that require significant mass, power, and maintenance. As a result, scientists have been looking for a sustainable way to create air in space.
This study focused on the phenomenon of magnetically-induced buoyancy. The researchers engineered a procedure to detach gas bubbles from electrode surfaces in microgravity environments at the Bremen Drop Tower. The results revealed for the first time that gas bubbles can be ‘attracted to’ and ‘repelled from’ a neodymium magnet in microgravity within various solutions.
According to Dr. Katharina Brinkert of the University of Warwick Department of Chemistry Center for Applied Space Technology and Microgravity (ZARM), “Efficient phase separation in reduced gravitational environments is an obstacle for human space exploration and known since the first flights to space in the 1960s. This phenomenon is a particular challenge for the life support system onboard spacecraft and the International Space Station (ISS) as oxygen for the crew is produced in water electrolyzer systems and requires separation from the electrode and liquid electrolyte.”
The results of this study could help generate breathable atmospheres for future space travel to the moon and Mars.
Space Travel’s Impact on the Body's Bone Mass & Stem Cells:

For those who stay in space for longer periods of time, the most prominent side effect is the loss of bone mass. New research now claims that living in space can also accelerate the process of bone aging, and irreparably damage bone structure.
The study assessed 14 male and three female astronauts, average age 47, whose missions ranged from four to seven months in space, with an average of about 5-1/2 months. The results showed that 1 year after their return from space, the astronauts on average exhibited 2.1% reduced bone mineral density at the tibia and 1.3% reduced bone strength. Nine of the 17 astronauts had not completely recovered a full year after returning from space.
"Astronauts experienced significant bone loss during six-month spaceflights - loss that we would expect to see in older adults over two decades on Earth, and they only recovered about half of that loss after one year back on Earth," Gabel said.
Additionally, another recent study focused on 14 astronauts from NASA’s space shuttle program whose white blood samples were stored for 20 years. Researchers found that the astronauts were more likely to have somatic mutations in their genes. The DNA mutations in blood-forming stem cells are at the root of several types of blood cancer.
Space Travel’s Impact on the Brain:
We know that space travel impacts the body, but what does it do to the brain? In this study, 12 cosmonauts who spent an average of six months aboard the International Space Station were scanned in an MRI scanner pre-flight, ten days after flight, and at a follow-up time point seven months after flight.
The results revealed "significant microstructural changes" in the white matter that manages communications within the brain, and to and from the rest of the body, as well as fluid shifts. In particular, the research team spotted changes in neural tracts related to sensory and motor functions, and believe this could have something to do with the cosmonauts' adaptation to life in microgravity while in outer space.
Whether through creating oxygen in outer space, or studying how travel impacts the brain and body, significant advances are being made in the space travel industry. For more data on patents and innovative research papers in the space travel field, visit cypris.ai and get started with access to the innovation dashboard.
If you’d like to explore recent patents filed, you can search through our global patent search engine for free here: https://cypris.ai/patents/allrecords
Sources:
Cypris innovation dashboard cypris.ai ; Query: space travel
https://www.precedenceresearch.com/space-tourism-market
https://interestingengineering.com/science/first-researchers-invent-oxygen-magnets-space-exploration
https://www.nature.com/articles/s41526-022-00212-9
https://www.sciencedaily.com/releases/2022/07/220729173222.htm
https://www.nature.com/articles/s41598-022-13461-1
https://www.slashgear.com/946243/scientists-discover-space-travel-accelerates-aging/
https://www.frontiersin.org/articles/10.3389/fncir.2022.815838/full

The brain processes 70,000 thoughts each day using 100 billion neurons that connect at more than 500 trillion points through synapses that travel 300 miles/hour. More and more, scientific advances are breaking down what's really going on behind these numbers. In this blog, we'll look at innovation in the area of artificial brain cells specifically.
Groundbreaking advances in artificial brain cell research are bridging the gap between man and machine, and paving the way for life-changing advances. Innovation in the artificial brain cell space is skyrocketing—experiencing a 61.79% growth rate over the past 5 years. The fastest growing category is Medical with an 133.33% increase in new patents filed over the last 5 years. Additionally, the IT Computing and Data Processing category is seeing a lot of filings by new entrants, so it might be an emerging space worth looking into.
Let’s take a look at the recent research that’s transforming the artificial brain cell space.
Artificial Neurons & Dopamine

Researchers at Nanjing University of Posts and Telecommunications and the Chinese Academy of Sciences in China and Nanyang Technological University and the Agency for Science Technology and Research in Singapore recently developed an artificial neuron with the ability to communicate using the neurotransmitter dopamine. Dopamine is our feel-good neurotransmitter, involved in the brain’s reward system.
The research team built an artificial neuron that can both release and receive dopamine. The neuron was made using graphene and a carbon nanotube electrode, to which they added a sensor to detect dopamine and a device called a memristor. If enough dopamine is detected by the sensor, a component called a memristor triggers the release of more dopamine at the other end through a heat-activated hydrogel.
To test the ability of the artificial neuron to communicate, they placed it in a petri dish alongside rat brain cells and found that the neuron was able to sense and respond to dopamine created and sent by the rat brain cells. The artificial neuron was also able to product some of its own, which triggered a response in the rat brain cells. Additionally, their results revealed that they could activate a small mouse muscle sample by sending dopamine to a sciatic nerve, which they use to move a robot hand.
Reviving Deceased Animal Brains
In 2019, Yale scientists restored cellular function in 32 pig brains that had been deceased for hours. The team used a system called BrainEx, which consisted of computer-controlled pumps and filters that sent a nourishing solution through a dead, surgically exposed brain, with an ebb and flow that mimics the body's natural circulation. The proprietary solution was based on hemoglobin, the oxygen-ferrying protein in red blood cells, and was made to show up during ultrasound scans, to enable researchers to track its flow through the brain. The process was found to restore circulation and oxygen flow to a dead brain.
Continuing their research, the same team published findings this month on reviving pig organs, rather than just the brain. Researchers connected pigs that had been dead for one hour to a system called OrganEx that pumped a blood substitute throughout the animals’ bodies. The solution they circulated contained the animal’s blood, as well as 13 compounds including as anticoagulants — to slow the decomposition of the bodies and quickly restore some organ function. Although OrganEx helped to preserve the integrity of some brain tissue, researchers did not observe any coordinated brain activity that would indicate the animals had regained any consciousness or sentience.
Graphene Synapses

A team at The University of Texas at Austin just published their research on how they developed synaptic transistors for brain-like computers using the thin, flexible material graphene. These transistors are similar to synapses in the human brain. Synapses connect neurons in the brain to neurons in the rest of the body and from those neurons to the muscles.
Graphene and nafion, a polymer membrane material, were used to create the backbone of the synaptic transistor. These materials demonstrate the ability for the pathways to strengthen over time as they are used more often, a type of neural muscle memory. When it comes to computing, this means that devices will improve in their ability and speed to recognize and interpret images over time.
Notably, these transistors are biocompatible, which means they can interact with living cells and tissue. For medical devices that interact with the human body, biocompatibility is key. Currently, most materials used for these early brain-like devices are toxic, so they would not be able to contact living cells.
Whether through creating artificial cells capable of transmitting and receiving dopamine, or reviving deceased brain cells in pigs, research is transforming our relationship to technology, and our understanding of the brain. To learn more about patents and new innovations in the artificial brain cell space, visit cypris.ai and get started with access to the innovation dashboard.
Sources:
https://www.nytimes.com/2022/08/03/science/pigs-organs-death.html
https://www.health.harvard.edu/mind-and-mood/dopamine-the-pathway-to-pleasure
Ting Wang et al, A chemically mediated artificial neuron, Nature Electronics (2022). DOI: 10.1038/s41928-022-00803-0
https://www.nature.com/articles/d41586-022-02112-0
https://techxplore.com/news/2022-08-graphene-synapses-advance-brain-like.html
https://www.miragenews.com/graphene-synapses-advance-brain-like-computers-833930/
https://healthybrains.org/brain-facts/#:~:text=Your brain is a three,that travel 300 miles%2Fhour.
Reports
Webinars
.png)

Most IP organizations are making high-stakes capital allocation decisions with incomplete visibility – relying primarily on patent data as a proxy for innovation. That approach is not optimal. Patents alone cannot reveal technology trajectories, capital flows, or commercial viability.
A more effective model requires integrating patents with scientific literature, grant funding, market activity, and competitive intelligence. This means that for a complete picture, IP and R&D teams need infrastructure that connects fragmented data into a unified, decision-ready intelligence layer.
AI is accelerating that shift. The value is no longer simply in retrieving documents faster; it’s in extracting signal from noise. Modern AI systems can contextualize disparate datasets, identify patterns, and generate strategic narratives – transforming raw information into actionable insight.
Join us on Thursday, April 23, at 12 PM ET for a discussion on how unified AI platforms are redefining decision-making across IP and R&D teams. Moderated by Gene Quinn, panelists Marlene Valderrama and Amir Achourie will examine how integrating technical, scientific, and market data collapses traditional silos – enabling more aligned strategy, sharper investment decisions, and measurable business impact.
Register here: https://ipwatchdog.com/cypris-april-23-2026/
.png)
In this session, we break down how AI is reshaping the R&D lifecycle, from faster discovery to more informed decision-making. See how an intelligence layer approach enables teams to move beyond fragmented tools toward a unified, scalable system for innovation.
.png)
In this session, we explore how modern AI systems are reshaping knowledge management in R&D. From structuring internal data to unlocking external intelligence, see how leading teams are building scalable foundations that improve collaboration, efficiency, and long-term innovation outcomes.
.avif)


%20-%20Competitive%20Benchmarking%20for%20Wearable%20%26%20Biosensor%20Device%20Manufacturers.png)